Genomic polymorphisms in sepsis

Mark T. Lin, Timothy E Albertson

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Objective: This article aims to review all relevant genetic polymorphism studies that may contribute to the pathogenesis of sepsis with emphasis on polymorphisms of the innate immunity, pro- and anti-inflammatory cytokines, and coagulation mediators. Data Source: Published articles reporting on studies of associations between genetic polymorphisms, sepsis, septic shock, and other relevant infectious disease models. Data Analysis: Research into the pathogenesis of sepsis has led to the development of many potential therapeutic strategies. Several therapeutic agents and treatment modalities have been shown to decrease mortality rates in large, prospective, and randomized clinical trials. However, although these advances have resulted in improved survival for certain patient populations, the overall mortality rate for septic patients remains high. With the rapid development of molecular and genetic techniques, substantial interests have developed in using genomic information to define disease-mediating genetic variants in sepsis. Combined with microarray technology, it is anticipated in the near future that one will be able to tailor drug selection and dosage and predict outcome by correlating genetic profile with disease presentation. Numerous genetic association studies in sepsis have already been reported and more are likely to be published. Conclusions: Although studies examined in this review are of small heterogeneous populations, the identification of strong associations between certain genetic polymorphisms and increased mortality rate or susceptibility to severe sepsis is intriguing and supports further research using this approach. The establishment of these associations does not equal causation, and further research is required in both genetic and molecular aspect of sepsis.

Original languageEnglish (US)
Pages (from-to)569-579
Number of pages11
JournalCritical Care Medicine
Volume32
Issue number2
DOIs
StatePublished - Feb 2004

Fingerprint

Sepsis
Genetic Polymorphisms
Mortality
Molecular Biology
Research
Genetic Techniques
Inborn Genetic Diseases
Information Storage and Retrieval
Genetic Association Studies
Septic Shock
Innate Immunity
Causality
Population
Communicable Diseases
Anti-Inflammatory Agents
Therapeutics
Randomized Controlled Trials
Cytokines
Technology
Survival

Keywords

  • Genetics
  • Immunity
  • Polymorphism
  • Sepsis

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Genomic polymorphisms in sepsis. / Lin, Mark T.; Albertson, Timothy E.

In: Critical Care Medicine, Vol. 32, No. 2, 02.2004, p. 569-579.

Research output: Contribution to journalArticle

Lin, Mark T. ; Albertson, Timothy E. / Genomic polymorphisms in sepsis. In: Critical Care Medicine. 2004 ; Vol. 32, No. 2. pp. 569-579.
@article{6827d3704dd74e9294238c856e59baa5,
title = "Genomic polymorphisms in sepsis",
abstract = "Objective: This article aims to review all relevant genetic polymorphism studies that may contribute to the pathogenesis of sepsis with emphasis on polymorphisms of the innate immunity, pro- and anti-inflammatory cytokines, and coagulation mediators. Data Source: Published articles reporting on studies of associations between genetic polymorphisms, sepsis, septic shock, and other relevant infectious disease models. Data Analysis: Research into the pathogenesis of sepsis has led to the development of many potential therapeutic strategies. Several therapeutic agents and treatment modalities have been shown to decrease mortality rates in large, prospective, and randomized clinical trials. However, although these advances have resulted in improved survival for certain patient populations, the overall mortality rate for septic patients remains high. With the rapid development of molecular and genetic techniques, substantial interests have developed in using genomic information to define disease-mediating genetic variants in sepsis. Combined with microarray technology, it is anticipated in the near future that one will be able to tailor drug selection and dosage and predict outcome by correlating genetic profile with disease presentation. Numerous genetic association studies in sepsis have already been reported and more are likely to be published. Conclusions: Although studies examined in this review are of small heterogeneous populations, the identification of strong associations between certain genetic polymorphisms and increased mortality rate or susceptibility to severe sepsis is intriguing and supports further research using this approach. The establishment of these associations does not equal causation, and further research is required in both genetic and molecular aspect of sepsis.",
keywords = "Genetics, Immunity, Polymorphism, Sepsis",
author = "Lin, {Mark T.} and Albertson, {Timothy E}",
year = "2004",
month = "2",
doi = "10.1097/01.CCM.0000110878.49476.42",
language = "English (US)",
volume = "32",
pages = "569--579",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Genomic polymorphisms in sepsis

AU - Lin, Mark T.

AU - Albertson, Timothy E

PY - 2004/2

Y1 - 2004/2

N2 - Objective: This article aims to review all relevant genetic polymorphism studies that may contribute to the pathogenesis of sepsis with emphasis on polymorphisms of the innate immunity, pro- and anti-inflammatory cytokines, and coagulation mediators. Data Source: Published articles reporting on studies of associations between genetic polymorphisms, sepsis, septic shock, and other relevant infectious disease models. Data Analysis: Research into the pathogenesis of sepsis has led to the development of many potential therapeutic strategies. Several therapeutic agents and treatment modalities have been shown to decrease mortality rates in large, prospective, and randomized clinical trials. However, although these advances have resulted in improved survival for certain patient populations, the overall mortality rate for septic patients remains high. With the rapid development of molecular and genetic techniques, substantial interests have developed in using genomic information to define disease-mediating genetic variants in sepsis. Combined with microarray technology, it is anticipated in the near future that one will be able to tailor drug selection and dosage and predict outcome by correlating genetic profile with disease presentation. Numerous genetic association studies in sepsis have already been reported and more are likely to be published. Conclusions: Although studies examined in this review are of small heterogeneous populations, the identification of strong associations between certain genetic polymorphisms and increased mortality rate or susceptibility to severe sepsis is intriguing and supports further research using this approach. The establishment of these associations does not equal causation, and further research is required in both genetic and molecular aspect of sepsis.

AB - Objective: This article aims to review all relevant genetic polymorphism studies that may contribute to the pathogenesis of sepsis with emphasis on polymorphisms of the innate immunity, pro- and anti-inflammatory cytokines, and coagulation mediators. Data Source: Published articles reporting on studies of associations between genetic polymorphisms, sepsis, septic shock, and other relevant infectious disease models. Data Analysis: Research into the pathogenesis of sepsis has led to the development of many potential therapeutic strategies. Several therapeutic agents and treatment modalities have been shown to decrease mortality rates in large, prospective, and randomized clinical trials. However, although these advances have resulted in improved survival for certain patient populations, the overall mortality rate for septic patients remains high. With the rapid development of molecular and genetic techniques, substantial interests have developed in using genomic information to define disease-mediating genetic variants in sepsis. Combined with microarray technology, it is anticipated in the near future that one will be able to tailor drug selection and dosage and predict outcome by correlating genetic profile with disease presentation. Numerous genetic association studies in sepsis have already been reported and more are likely to be published. Conclusions: Although studies examined in this review are of small heterogeneous populations, the identification of strong associations between certain genetic polymorphisms and increased mortality rate or susceptibility to severe sepsis is intriguing and supports further research using this approach. The establishment of these associations does not equal causation, and further research is required in both genetic and molecular aspect of sepsis.

KW - Genetics

KW - Immunity

KW - Polymorphism

KW - Sepsis

UR - http://www.scopus.com/inward/record.url?scp=1242320032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1242320032&partnerID=8YFLogxK

U2 - 10.1097/01.CCM.0000110878.49476.42

DO - 10.1097/01.CCM.0000110878.49476.42

M3 - Article

C2 - 14758181

AN - SCOPUS:1242320032

VL - 32

SP - 569

EP - 579

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 2

ER -